Govt. urged to revoke patent on cancer drug 

#GS2 #Governance 

  • The efficacy of the drug in curing extremely sick COVID-19 patients, particularly those requiring ventilator assistance, is still being investigated. 
  • The CPAA said the patent on the drug would make it unaffordable and this would include cancer patients who are at heightened risk of complications from the viral infection. 
  • The Indian patent on Remdesivir was granted as recently as February 18. The Association said the patent ought to be revoked not only on the grounds that it could incentivize other manufacturers to make the drug and offer it cheaply but also on the grounds that the drug wasn’t “novel.” 
Print Friendly and PDF
blog comments powered by Disqus